Пошук
Psychoactive Substances
Psychoactive substances are natural or synthetic substances that act on the central nervous system and alter mental processes such as mood, perception, cognition, consciousness, and behaviour. These substances may be legally prescribed medications (e.g., pain medications or sedatives), legally available substances such as alcohol or caffeine, or controlled or illicit drugs. Psychoactive substances can be used for medical, social, cultural, or recreational purposes, but some carry risks of misuse, dependence, and health or social harms when used in harmful ways.
Лікування та профілактика розладів, пов'язаних із вживанням психоактивних речовин на робочому місці
ISSUP Кенія представляє свій вебінар про використання речовин на робочому місці.
Family Day: NGO launches an information guide for parents
A l’occasion de la journée internationale de la famille, célébrée le 15 mai de chaque année, l’ONG RAPAA (Recherche Action Prévention Accompagnement des Addictions) a organisé une cérémonie de lancement d’un guide destiné aux familles...
MPSP se manifesta contra a descriminalização do porte de drogas para consumo pessoal
Dr. Mario Luiz Sarrubbo, Procurador-Geral da Justiça do Estado de São Paulo, protocolizou um memorial no Supremo Tribunal Federal – STF com o posicionamento do Ministério Público paulista sobre a pauta que trata da possível...
Increase in driving after cocaine use in Spain: a cross-sectional dataset analysis for 2021
Objective: Driving under the influence of alcohol and/or drugs impairs skills essential for safe driving, increases the risk of being involved in a traffic accident and is particularly prevalent in Spain. The aim is to assess the prevalence...
Наслідки вживання копченого канабісу у шкільних підлітків
ISSUP Chile представила вебінар на тему «Ефекти вживання куріння канабісу у шкільних підлітків».
Зменшення стигматизації щодо людей, які живуть з ВІЛ, та людей, які вживають ін'єкційні наркотики
Незважаючи на численні докази негативних наслідків стигматизації, з якими стикаються люди, які живуть з ВІЛ (ЛЖВ) та люди, які вживають ін'єкційні наркотики в закладах охорони здоров'я, існує порівняно мало доказів ефективності ініціатив...
Споживання психоактивних речовин у зразках гватемальського шкільного населення
Було проведено дослідження, що складається з 4 магістерських дипломних робіт зі змішаною описовою методологією, які стосуються різних факторів ризику, що викликають студентів у Гватемалі, які потрапляють у проблеми використання, споживання...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
Teens and substance use — what can parents do?
Objective: To help adults manage risks relating to adolescent substance use in line with evidence-based prevention principles.
Background: Smoking and drinking among 15–16-year-old school students are showing signs of decline, but there...
Understanding the risks of mixing drugs
February 17, 2022
Mixing drugs, also known as polysubstance use, occurs when two or more drugs are taken together or within a short time period, intentionally or unintentionally. Even if someone has mixed drugs before, or mixes drugs often...
Факти про використання поліречовини
Що таке використання поліречовини?
Використання більш ніж одного препарату, також відоме як вживання поліречовин, є звичайним явищем. Це стосується випадків, коли два або більше з них зроблені разом або протягом короткого періоду часу...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Strategies to Address Cocaine and Methamphetamine
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
UNODC supported delegations from four Central Asian countries in a high-level study tour to the United Kingdom
The UNODC Regional Office for Central Asia (ROCA) together with the UNODC Prevention, Treatment and Rehabilitation Section (PTRS) organized a study tour for high-level representatives, including senior officials, policymakers and substance...
72º Regular Session of the Inter-American Drug Abuse Control Comission was held
In the magazine CIJ Informa, the participation of CIJ, host chapter institution of ISSUP Mexico, in the 71st Regular Session of CICAD is reviewed.
The Anti-Stigma Network
The Anti-Stigma Network has been launched!
The Mission
The Anti-Stigma Network has been created by a group of organisations coming together with a shared mission.
Collectively they aim to improve understanding of the stigma and...
Buprenorphine versus methadone for the treatment of opioid dependence
Summary
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review
Abstract
Objective
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Comparison of Treatments for Cocaine Use Disorder Among Adults
Key Points
Question What treatments for cocaine use disorder are associated with objective reductions in cocaine use among adults?
Findings In this meta-analysis of 157 clinical trials comprising 402 treatment groups and 15 842...